900148
Iron oxide (II,III), nanoparticles
30 nm avg. part. size (TEM), streptavidin functionalized, 1 mg/mL in H2O
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.23
UNSPSC Code:
12352303
Quality Level
form
dispersion, nanoparticles
packaging
pkg of 1 mL
storage condition
do not freeze
concentration
1 mg/mL in H2O
avg. part. size
30 nm (TEM)
functional group
streptavidin
storage temp.
2-8°C
General description
Recent docking studies highlight the potential interaction of iron oxide (II,III) nanoparticles (IONPs) with the SARS-CoV-2 spike protein receptor binding domain. This may target viral entry in host cells and also render virions inactive.
Application
IONPs may be used in the nanoparticle preparation for evaluation of their antiviral property against H1N1 influenza A virus.
Iron oxide nanoparticles exhibit biocompatibility and non-toxicity and are used as magnetic resonance imaging contrast agents, gene carriers for gene therapy, therapeutic agents for hyperthermia-based cancer treatment, magnetic sensing probes for in vivo diagnostics and for target specific drug delivery.
Legal Information
Product of Ocean Nanotech, LLC.
Still not finding the right product?
Explore all of our products under Iron oxide (II,III), nanoparticles
Storage Class
12 - Non Combustible Liquids
wgk
WGK 2
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Prof. Yadong Yin discusses various synthesis methods of magnetite nanocrystals and their applications in different fields.
Professor Hui Mao explores the use of superparamagnetic iron oxide nanoparticles (INOPs) that offer an alternate contrast-enhancing mechanism.
A Molecular Docking Study Repurposes FDA Approved Iron Oxide Nanoparticles to Treat and Control COVID-19 Infection
Abo-Zeid Y, et al.
European Journal of Pharmaceutical Sciences, 105465-105465 (2020)
Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus
Kumar R, et al.
Journal of Infection and Chemotherapy, 25(5), 325-329 (2019)
Joan Estelrich et al.
International journal of molecular sciences, 16(4), 8070-8101 (2015-04-14)
In this review, we discuss the recent advances in and problems with the use of magnetically-guided and magnetically-responsive nanoparticles in drug delivery and magnetofection. In magnetically-guided nanoparticles, a constant external magnetic field is used to transport magnetic nanoparticles loaded with
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 900148-1ML | 04061833219881 |